[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE0101659D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE0101659D0
SE0101659D0 SE0101659A SE0101659A SE0101659D0 SE 0101659 D0 SE0101659 D0 SE 0101659D0 SE 0101659 A SE0101659 A SE 0101659A SE 0101659 A SE0101659 A SE 0101659A SE 0101659 D0 SE0101659 D0 SE 0101659D0
Authority
SE
Sweden
Prior art keywords
new compounds
compounds
new
Prior art date
Application number
SE0101659A
Other languages
English (en)
Inventor
Patrizia Caldirola
Annika Jensen
Gary Johansson
Andrew Mott
Marianne Nilsson
Jan Tejbrant
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE0101659A priority Critical patent/SE0101659D0/sv
Publication of SE0101659D0 publication Critical patent/SE0101659D0/sv
Priority to AU2002303061A priority patent/AU2002303061B2/en
Priority to PL02366619A priority patent/PL366619A1/xx
Priority to CA002443724A priority patent/CA2443724C/en
Priority to YUP-888/03A priority patent/RS88803A/sr
Priority to KR1020097014381A priority patent/KR20090092832A/ko
Priority to MXPA03010232A priority patent/MXPA03010232A/es
Priority to BR0209558-0A priority patent/BR0209558A/pt
Priority to EP02769640A priority patent/EP1406884A1/en
Priority to CNB028096142A priority patent/CN1329382C/zh
Priority to KR1020037014656A priority patent/KR100922486B1/ko
Priority to EA200301232A priority patent/EA009647B1/ru
Priority to IL15859302A priority patent/IL158593A0/xx
Priority to NZ528450A priority patent/NZ528450A/en
Priority to JP2002589470A priority patent/JP4597480B2/ja
Priority to PCT/SE2002/000906 priority patent/WO2002092585A1/en
Priority to US10/143,335 priority patent/US7173035B2/en
Priority to US10/144,677 priority patent/US6969710B2/en
Priority to ZA200307953A priority patent/ZA200307953B/en
Priority to IL158593A priority patent/IL158593A/en
Priority to NO20034996A priority patent/NO326690B1/no
Priority to HK05100327A priority patent/HK1068335A1/xx
Priority to US11/215,173 priority patent/US7566715B2/en
Priority to US11/214,523 priority patent/US7319097B2/en
Priority to US11/960,045 priority patent/US7718650B2/en
Priority to IL194950A priority patent/IL194950A0/en
Priority to JP2010157953A priority patent/JP2011016801A/ja

Links

SE0101659A 2001-05-11 2001-05-11 New compounds SE0101659D0 (sv)

Priority Applications (27)

Application Number Priority Date Filing Date Title
SE0101659A SE0101659D0 (sv) 2001-05-11 2001-05-11 New compounds
PCT/SE2002/000906 WO2002092585A1 (en) 2001-05-11 2002-05-08 Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
IL15859302A IL158593A0 (en) 2001-05-11 2002-05-08 Novel, arylsulfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
JP2002589470A JP4597480B2 (ja) 2001-05-11 2002-05-08 肥満、ｉｉ型糖尿病およびｃｎｓ疾患の処置のための新規アリールスルホンアミド化合物
CA002443724A CA2443724C (en) 2001-05-11 2002-05-08 Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
YUP-888/03A RS88803A (en) 2001-05-11 2002-05-08 Novel-arylsulfonamide compounds for the treatment of obesity type ii diabetes and cns-disorders
KR1020097014381A KR20090092832A (ko) 2001-05-11 2002-05-08 비만, 제 ⅱ 형 당뇨병 및 ｃｎｓ 장애의 치료를 위한 신규한 아릴술폰아미드 화합물
MXPA03010232A MXPA03010232A (es) 2001-05-11 2002-05-08 Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central.
BR0209558-0A BR0209558A (pt) 2001-05-11 2002-05-08 Novos compostos de arilsulfonamida para o tratamento de obesidade, diabetes tipo ii e distúrbios do snc
EP02769640A EP1406884A1 (en) 2001-05-11 2002-05-08 Arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
CNB028096142A CN1329382C (zh) 2001-05-11 2002-05-08 治疗肥胖、ⅱ型糖尿病和cns－疾病的芳基磺酰胺化合物
KR1020037014656A KR100922486B1 (ko) 2001-05-11 2002-05-08 비만, 제 ⅱ 형 당뇨병 및 ｃｎｓ 장애의 치료를 위한신규한 아릴술폰아미드 화합물
EA200301232A EA009647B1 (ru) 2001-05-11 2002-05-08 Арилсульфонамидные соединения и их применение для лечения ожирения и диабета типа ii
AU2002303061A AU2002303061B2 (en) 2001-05-11 2002-05-08 Novel, arylsulfonamide compounds for the treatment of obesity, type II diabetes and CNS-disorders
NZ528450A NZ528450A (en) 2001-05-11 2002-05-08 Novel, arylsulfonamide compounds for the treatment of obesity, type II diabetes and CNS-disorders
PL02366619A PL366619A1 (en) 2001-05-11 2002-05-08 Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
US10/143,335 US7173035B2 (en) 2001-05-11 2002-05-10 Arylsulfonamide compounds
US10/144,677 US6969710B2 (en) 2001-05-11 2002-05-13 Compounds
ZA200307953A ZA200307953B (en) 2001-05-11 2003-10-13 Novel, Arylsusfonamide compounds for the treatment of obesity, Type II diabetes and CNS-disorders.
IL158593A IL158593A (en) 2001-05-11 2003-10-23 Arylsulfonamide compounds, process for preparation thereof and pharmaceutical compositions for the treatment of obesity, type ii diabetes and cns-disorders
NO20034996A NO326690B1 (no) 2001-05-11 2003-11-10 Nye arylsusfonamidforbindelser for behandlingen av fedme og type II diabetes, fremgangsmåte for fremstilling derav, samt farmasøytiske formuleringer som inneholder slike
HK05100327A HK1068335A1 (en) 2001-05-11 2005-01-13 Novel arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
US11/215,173 US7566715B2 (en) 2001-05-11 2005-08-30 Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system
US11/214,523 US7319097B2 (en) 2001-05-11 2005-08-30 Compounds
US11/960,045 US7718650B2 (en) 2001-05-11 2007-12-19 Aryl sulfonamide compounds for treating obesity
IL194950A IL194950A0 (en) 2001-05-11 2008-10-27 Novel, arylsulfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
JP2010157953A JP2011016801A (ja) 2001-05-11 2010-07-12 肥満、ｉｉ型糖尿病およびｃｎｓ疾患の処置のための新規アリールスルホンアミド化合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101659A SE0101659D0 (sv) 2001-05-11 2001-05-11 New compounds

Publications (1)

Publication Number Publication Date
SE0101659D0 true SE0101659D0 (sv) 2001-05-11

Family

ID=20284069

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0101659A SE0101659D0 (sv) 2001-05-11 2001-05-11 New compounds

Country Status (2)

Country Link
SE (1) SE0101659D0 (sv)
ZA (1) ZA200307953B (sv)

Also Published As

Publication number Publication date
ZA200307953B (en) 2004-10-13

Similar Documents

Publication Publication Date Title
IS6971A (is) Ný efnasambönd
IS7016A (is) Ný 4-anilínókínólín-3-karboxamíð
ATE402148T1 (de) Substituierte pyridinylamine
DE50206892D1 (de) Substituierte imidazotriazinone
DK1373228T3 (da) Substituerede fluoralkoxyphenylsulfonylurinstoffer
DK1406858T3 (da) Substituerede 4-aminocyklohexanoler
ATA18372001A (de) Gelenksbolzenbaueinheit
ATA13992002A (de) Schlackengranulierungsanlage
DE60216967D1 (de) Substituierte cyclohexanderivate
AT500276B8 (de) Radschwenksystem
SE0102386D0 (sv) New compounds
SE0103437D0 (sv) New compounds
SE0102056D0 (sv) New Compounds
SE0101958D0 (sv) New compounds
SE0101660D0 (sv) New compounds
SE0101659D0 (sv) New compounds
SE0104366D0 (sv) New compounds
SE0104342D0 (sv) New compounds
SE0100629D0 (sv) New compounds
SE0103461D0 (sv) New compounds
SE0100272D0 (sv) New compounds
SE0100641D0 (sv) Novel compounds
SE0103271D0 (sv) Novel compounds
SE0104474D0 (sv) Novel Compounds
SE0200704D0 (sv) Novel compounds